Corpus Intelligence IC Memo — BAPTIST HEALTH MED CTR ARKADELPHIA 2026-04-26 04:05 UTC
IC Memo — BAPTIST HEALTH MED CTR ARKADELPHIA
Investment Committee Memorandum | AR | 25 beds | Grade C | EBITDA uplift $2.2M
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

BAPTIST HEALTH MED CTR ARKADELPHIA

CCN 041321 | CLARK, AR | 25 beds | April 26, 2026
EBITDA BridgeData Room
C
Investability

1. Target Overview & Investment Thesis

BAPTIST HEALTH MED CTR ARKADELPHIA is a 25-bed suburban community hospital in CLARK, AR with $30.1M in net patient revenue and a -3.1% operating margin. The hospital serves a payer mix of 30.6% Medicare, 13.6% Medicaid, and 55.8% commercial.

Thesis: Turnaround. Our ML models identify $2.2M in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -3.1% to 4.2% (+736bps).

Net Revenue HCRIS$30.1M
Current EBITDA COMPUTED$-948K
Operating Margin COMPUTED-3.1%
Occupancy HCRIS30.9%
Revenue / Bed COMPUTED$1.2M
Net-to-Gross HCRIS30.8%
Distress Probability ML54.9%

2. Market Context & Competitive Position

108
AR Hospitals
-7.6%
State Median Margin
52
Comparable Hospitals

AR has 108 Medicare-certified hospitals with a median operating margin of -7.6%. The target's margin of -3.1% places it above the state median. Among 52 size-comparable peers (12-50 beds), the median margin is -15.1%. The target performs in line with or above peers.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (12-50), prioritizing same-state peers. 52 hospitals in the comp set.

HospitalStateBedsRevenueMargin
BAPTIST HEALTH MED CTR ARKADEL (Target)AR25$30.1M-3.1%
ARKANSAS CHILDRENS NORTHWESTAR24$113.6M7.2%
ARKANSAS SURGICAL HOSPITALAR47$75.1M11.7%
ENCORE MEDICAL CENTERAR25$55.7M-4.7%
OZARKS COMMUNITY HOSPITAL OF GAR25$48.6M-21.0%
DREW MEMORIAL HOSPITAL INCAR49$35.3M-27.2%
ASHLEY COUNTY MEDICAL CENTERAR25$33.7M-23.0%
OZARK HEALTH INCAR25$32.3M-4.7%
FORREST CITY MEDICAL CENTERAR48$30.3M-17.3%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $2.2M (736bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Net Collection Rate93.5%97.0%$633K+210bp18mo
Cost to Collect4.5%2.5%$603K+200bp12mo
Denial Rate Reduction12.0%6.5%$597K+198bp12mo
A/R Days Reduction5200.0%3800.0%$367K+122bp9mo
Clean Claim Rate88.0%96.0%$19K+6bp6mo

5. EBITDA Bridge

Net Collection Rate
$633K
Cost to Collect
$603K
Denial Rate Reduction
$597K
A/R Days Reduction
$367K
Clean Claim Rate
$19K
Total EBITDA Uplift$2.2M
Current EBITDA$-948K
+ RCM Uplift+$2.2M
Pro Forma EBITDA$1.3M
Current Margin-3.1%
Pro Forma Margin4.2%
WC Released (1x)$1.2M

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-1.5M$15.9M0.00x-100.0%
Base (11x exit)10.0x11.0x$-1.5M$17.1M0.00x-100.0%
Bull Case9.0x11.0x$-1.3M$23.9M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-1.3M$25.7M0.00x-100.0%
Bear Case11.0x10.0x$-1.6M$5.3M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-1.6M$5.3M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion
MediumLow occupancyAt 30.9%, fixed costs are spread over fewer patient days. Mitigant: volume growth is an additional upside lever not modeled in base case
HighElevated distress probabilityModel estimates 54.9% probability of financial distress. Mitigant: distressed entry pricing (7-9x) compensates for risk

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 52 hospitals with 12-50 beds
  • Same-state prioritization (n=53)
  • Comp margins: P25=-24.5% / P50=-15.1% / P75=-0.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.